Rigel Pharmaceuticals
RIGL
#6718
Rank
NZ$0.82 B
Marketcap
$46.77
Share price
0.70%
Change (1 day)
243.91%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$0.27 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's total liabilities are NZ$0.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Rigel Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$0.23 B-0.98%
2022-12-31NZ$0.23 B16.18%
2021-12-31NZ$0.20 B89.48%
2020-12-31NZ$0.10 B-23.99%
2019-12-31NZ$0.13 B219.44%
2018-12-31NZ$43.57 M67.62%
2017-12-31NZ$25.99 M-22.06%
2016-12-31NZ$33.35 M-43.44%
2015-12-31NZ$58.97 M78.5%
2014-12-31NZ$33.04 M52.48%
2013-12-31NZ$21.66 M-14.9%
2012-12-31NZ$25.46 M-5.17%
2011-12-31NZ$26.85 M0.74%
2010-12-31NZ$26.65 M-37.3%
2009-12-31NZ$42.51 M-37.85%
2008-12-31NZ$68.39 M55.9%
2007-12-31NZ$43.87 M18.83%
2006-12-31NZ$36.92 M-35.43%
2005-12-31NZ$57.17 M53.83%
2004-12-31NZ$37.16 M55.36%
2003-12-31NZ$23.92 M-33.76%
2002-12-31NZ$36.11 M-14.34%
2001-12-31NZ$42.16 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$0.11 B-56.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$110.46 B 40,792.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$142.22 B 52,549.66%๐Ÿ‡บ๐Ÿ‡ธ USA